Risk factors for severe hypoglycemia in black and white adults with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

Diabetes Care

Volumn 40, Issue 12, 2017, Pages 1661-1667

  Lee, Alexandra K ^a   Lee, Clare J ^b   Huang, Elbert S ^c   Sharrett, A Richey ^a   Coresh, Josef ^a   Selvin, Elizabeth ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; ANTIDEPRESSANT AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ADULT; AMBULANCE TRANSPORTATION; ARTICLE; BLACK PERSON; CAUCASIAN; COGNITION; COGNITIVE DEFECT; COMMUNITY ASSESSMENT; DAILY LIFE ACTIVITY; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY CARE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; ICD-9; KIDNEY INJURY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAID; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; AGED; ATHEROSCLEROSIS; BLOOD; COMPLICATION; ETHNIC GROUP; ETHNOLOGY; GLUCOSE BLOOD LEVEL; INCIDENCE; METABOLISM; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; AGED; ANTIDEPRESSIVE AGENTS; ATHEROSCLEROSIS; BLOOD GLUCOSE; COGNITION; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 85036659240     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-0819     Document Type: Article

References (41)

1. Laiteerapong N, Karter AJ, Liu JY, et al. Correlates of quality of life in older adultswith diabetes: the diabetes & aging study. Diabetes Care 2011; 34:1749-1753
2. Zoungas S, Patel A, Chalmers J, et al.; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-1418
3. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909
4. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications andmortality in older patients with diabetesmellitus: the diabetes and aging study. JAMA Intern Med 2014;174:251-258
5. American Diabetes Association. Standards of medical care in diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S131
6. Miller ME, Bonds DE, Gerstein HC, et al.; ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340:b5444
7. Yun JS, Ko SH, Ko SH, et al. Cardiovascular disease predicts severe hypoglycemia in patients with type 2 diabetes. Diabetes Metab J 2015;39: 498-506
8. Lipska KJ, Ross JS, Wang Y, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014;174: 1116-1124
9. Karter AJ, Laiteerapong N, Chin MH, et al. Ethnic differences in geriatric conditions and diabetes complications among older, insured adults with diabetes: the Diabetes and Aging Study. J Aging Health 2015;27:894-918
10. Karter AJ, Lipska KJ, O'Connor PJ, et al.; SUPREME-DM Study Group. High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network. J Diabetes Complications 2017;31:869-873
11. Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasquín B, Sánchez-Castellano C, Sánchez-García E. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc 2013;61:734-738
12. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702
13. Levey AS, Stevens LA, Schmid CH, et al.; CKDEPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604-612
14. Punthakee Z, Miller ME, Launer LJ, et al.; ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012;35:787-793
15. Pathak R, Schroeder EB, Seaquist ER, et al. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011. Diabetes Care 2016;39:363-370
16. Derijks HJ, Heerdink ER, De Koning FH, Janknegt R, Klungel OH, Egberts AC. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiol Drug Saf 2008;17: 336-344
17. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 2006;5: 157-168
18. Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 1998;19:491-503
19. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
20. Lee AK, McEvoy JW, Hoogeveen RC, Ballantyne CM, Selvin E. Severe hypoglycemia and elevated high-sensitivity cardiac troponin T in older adults with diabetes: the ARIC Study. J Am Coll Cardiol 2016;68:1370-1371
21. Klimontov VV, Myakina NE. Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin. Diabetes Metab Syndr 2017;11:119-124
22. Qu Y, Jacober SJ, Zhang Q, Wolka LL, DeVries JH. Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data. Diabetes Technol Ther 2012;14:1008-1012
23. Ginde AA, Blanc PG, Lieberman RM, Camargo CA Jr. Validation of ICD-9-CMcoding algorithmfor improved identification of hypoglycemia visits. BMC Endocr Disord 2008;8:4
24. Leese GP, Wang J, Broomhall J, et al.; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003; 26:1176-1180
25. 1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care 2013;36:3535-3542
26. ORIGIN Trial Investigators. Predictors of nonsevere and severe hypoglycemia during glucoselowering treatmentwith insulin glargine or standard drugs in the ORIGIN trial. Diabetes Care 2015;38: 22-28
27. Cahn A, Raz I, Mosenzon O, et al. Predisposing factors for any and major hypoglycemia with saxagliptin versus placebo and overall: analysis from the SAVOR-TIMI 53 Trial. Diabetes Care 2016;39:1329-1337
28. Green AJ, Fox KM, Grandy S; SHIELD Study Group. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract 2012;96:313-318
29. Kikuchi Y, Iwase M, Fujii H, et al. Association of severe hypoglycemia with depressive symptoms in patients with type 2 diabetes: the Fukuoka Diabetes Registry. BMJ Open Diabetes Res Care 2015;3:e000063
30. Bruce DG, Davis WA, Casey GP, et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 2009;52:1808-1815
31. Yaffe K, Falvey CM, Hamilton N, et al.; Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013; 173:1300-1306
32. Sawicki PT, Siebenhofer A. Betablocker treatment in diabetes mellitus. J Intern Med 2001;250: 11-17
33. ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000;23:1467-1471
34. Yun JS, Ko SH, Ko SH, et al. Presence ofmacroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care 2013;36:1283-1289
35. Hodge M, McArthur E, Garg AX, Tangri N, Clemens KK. Hypoglycemia incidence in older adults by estimated GFR. Am J Kidney Dis 2017; 70:59-68
36. Davis TME, Brown SGA, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010;95:2240-2247
37. Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med 2015;175:356-362
38. Thorpe CT, Gellad WF, Good CB, et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care 2015;38:588-595
39. Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, et al. Appropriate prescribing for patients with diabetes at high risk for hypoglycemia: national survey of Veterans Affairs Health Care Professionals. JAMA Intern Med 2015;175:1994-1996
40. Mühlbacher A, Bethge S. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences. Eur J Health Econ 2016;17:1125-1140
41. Rodriguez-Gutierrez R, Gionfriddo MR, Ospina NS, et al. Shared decision making in endocrinology: present and future directions. Lancet Diabetes Endocrinol 2016;4:706-716